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Abstract-In the simplest model of protein production, a gene
gives rise to a single protein; DNA is transcribed to form pre-
mRNA, which is converted to mRNA by splicing or removing
introns. The result is a chain of exons that is translated to form a
protein. Alternative splicing of exons may result in the formation
of multiple proteins from the same gene sequence. However, not
all of these proteins may be functional. Thus, we ask whether we
can predict and rank (in order of frequency of occurrence and
functional importance) the set of possible proteins for a gene.
Herein we describe a tool that predicts the relative frequencies of
isoforms that can be produced from a given gene.
Keywords-alternative splicing; isoforms; proteinfrequency
I. INTRODUCTION
Genes are composed of coding and non-coding regions
(exons and introns, respectively). The simplest model of
protein production dictates that one gene encodes for one
protein, as shown in Fig. IA. The gene is first transcribed into
pre-mRNA, which includes both exons and introns. The pre-
mRNA is then transcribed into mature mRNA, in which the
intron regions are spliced out, leaving exons. Due to the
phenomenon of alternative splicing, however, a single gene
can encode for multiple proteins, as shown in Fig. lB. This is
possible because in every transcription event there are
controlling elements that can include or exclude different
regions of the gene. Thus, different transcription events can
result in versions of the protein that differ slightly from each
other. These different versions are called isoforms.
Alternative splicing occurs in most eukaryotes, and most
genes display alternative splicing [1, 2]. Despite the growing
significance of alternative splicing to many biological
processes, our understanding of alternative splicing is limited,
and its control mechanisms are poorly known [2].
Given the potential significance of alternative splicing, we
wish to know if, given an arbitrary gene, we can predict and
rank (in order of frequency of occurrence) the set of possible
protein isoforms that could result from it. Herein we describe
a tool that utilizes GenBank data to predict the relative
frequencies of proteins that can be produced from a given
gene. Although there are seven basic methods of alternative
splicing [3], as proof of concept, we only consider cassette








Figure 1. A) Simple model of eukaryotic protein formation. Introns are
spliced out of pre-mRNA to form mature mRNA, which is translated to
produce a single protein. B) An alternate model of eukaryotic protein
formation. Alternative splicing results in several different forms of mature
mRNA, resulting in several different proteins from the same gene sequence.
II. RELATED WORK
Traditionally, alternative splicing has been considered an
exceptional event, occurring in only about 500 ofhuman genes
[4]. More recently this view has been challenged by several
studies, which showed that between 50-75°O of human and
mouse genes are alternatively spliced [1, 5, 6].
Stamm [6] found that alternative splicing is more the rule
than the exception. A comparison of expressed sequence tags
(ESTs) and the human genome indicated that as much as 4700
of human genes might be alternatively spliced. Alternative
splicing explains how 23,000-40,000 genes can create a
proteome consisting of an estimated 90,000 proteins. Studies
show that 80% of the variability in proteins lies within the
coding region, resulting in different isoforms [2]. Alternative
splicing can alter the expression and function of a protein by
adding or removing specific domains [5].
Takeda et al. [7] conducted the first genome-wide
identification and characterization of alternative splicing in
human gene transcripts (based on full-length cDNAs).
Neverov et al. [8] developed a method to find possible mRNA
isoforms for human genes contained in the EST Derived
Alternative Splicing (EDAS) database. Nakao et al. [9]
classified isoforms and studied the co-occurrence of these
isoforms for each gene. It is clear from these recent
discoveries that alternative splicing during protein formation
is an important factor affecting future research in the areas of
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health, embryology, and evolution. For example, a recent
study [10] showed that one of the major impacts of alternative
splicing is in the removal of protein-to-protein interactions.
Thus, it is assumed that alternative splicing is a significant
process that gives rise to functional complexity [3].
III. APPROACH
Because of the importance of alternative splicing to
isoform formation and the subsequent effects on protein
diversity, we investigated the use of a simple data mining
strategy to determine whether existing data could be utilized
to predict the set of possible isoforms that could occur from
the alternative splicing of an arbitrary gene. Although there is
a variety of methods for alternative splicing, as a first
approach we examined cassette exon splicing because it is the
most common type of splicing, and because of the simplicity
with which it can be analyzed computationally.
We considered various existing search and retrieval
systems that could be used to obtain exon structure
information. Websites such as NCBI's Entrez are quite
informative, but the reference assembly information (i.e., the
sequence of nucleotides of a genome in GenBank) does not
necessarily include the start and end positions of the exon,
which is essential for our analysis. We investigated various
exon-finding tools such as Augustus (augustus.gobics.
de/submission) and FirstEF (rulai.cshl.edu /tools/FirstEF/),
which do provide information about exon start and end
positions. However, these tools did not always return the
same exon structure information for the same nucleotide, and
thus, could not be relied upon to provide consistent results
necessary for this project. Instead we chose to utilize NCBI's
Consensus CDS protein set (www.ncbi.nlm.nih
.gov/projects/CCDS), which provides high quality annotation
of human and mouse protein-coding regions. It should be
noted, however, that not all human or mouse genes are
available via CCDS, and the exon structures for the mouse
version of four genes we examined were not available. Thus
we only analyzed 15 human genes and 11 mouse genes.
We assumed that the frequency of an isoform is
proportional to the number of occurrences of that isoform in
GenBank. Because GenBank includes partially transcribed
genes, we allowed for partial occurrences of isoforms. Since
isoforms are similar to one another, our frequency metric
needed to be sensitive to small changes. We accomplished
this by defining a region of interest (corresponding to the
splice site) in a query (= a nucleotide sequence). When a
record matched GenBank with our query, we scored it as a
match if part or all of the region of interest was matched.
Our overall approach was to: (1) find the exon structure
for a given gene using CCDS; (2) form a set of queries with
each query corresponding to a possible isoform; (3) determine
the alignment of a particular query set using BLAST; and (4)
process each query result to calculate alternative splicing
scores as the basis for predicting which isoforms are most
likely, and thus, are potentially functionally important.
A. Algorithm




1. Find exon structure for gene G from CCDS.
2. Form the query sets.
3. BLAST each query.
4. Process each query to find alternative splicing and
their respective frequencies.
Once the exon structure is determined (Step 1), query sets
are built that include all of the possible combinations of exons
skipped. If there are N exons in a gene sequence, the number
of isoforms (and thus the number of queries) resulting from
all possible exon skipping events is 2N 1. Thus, for a set of
five exons, there would be 25 1, or 31, queries.
Once the query set is generated, a BLAST search of
GenBank is conducted for each combination (or possible
skipping event) in the set. The search returns a list of all
possible local alignments for that query, hereafter referred to
as matches. To calculate the frequency (or score) for an
isoform with an alternative splicing occurrence, three pieces
of information from the results are required: query id (
isoform id), query start position, and query end position.
B. Calculating the Frequency ofIsoforms
The frequency of an isoform is calculated in Step 4 of our
algorithm. First, we extract all matches as described above.
For each match, we calculate the overlap score as follows.
Suppose we are trying to calculate the overlap score for the
query e1e3e4e5 (a query in which exon e2 is skipped) and a
match X, the result returned by BLAST. We compute the
overlap of X and the possible isoform by computing the
overlap of X with the exons that lie on either side of the
skipped exon(s). In this example, we compute the overlap, or
fraction of nucleotides locally aligned, between X and exon 1
(fl), and between X and exon 3 (f2). The minimum overlap is
then calculated as min {fl, f2}.
The minimum is taken to ensure that there is significant
overlap with both exon 1 and exon 3. Referring to Fig. 2, for
Match 1 we see that there is 0.8 (or an 80%) match with exon
3, and 0.2 match with exon 1. Thus, the minimum overlap for
Match 1 is 0.2. Similarly, the minimum overlap for Match 3 is
0.9 (as shown in Table I). Because we want to exclude small
insignificant overlaps, a threshold value is assigned to add
confidence to the overlap. For example, in the queries
considered in Fig. 2, an arbitrary threshold of 0.3 is used,
meaning that if the minimum overlap is not 0.3 or greater,
then the match is not considered to be significant.
By comparing the minimum overlap values with the
threshold values, overlap scores are assigned for each query.
In the example shown in Table I, the threshold is set at 0.3
and the minimum overlap of Match 1 is 0.2; thus, this match
is not deemed significant, and is assigned an overlap score of
0. Similarly, the minimum overlap of Match 3 is 0.9,
indicating a significant match, and the overlap score assigned
is the same as the minimum overall (0.9). Overlap scores are
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calculated for the remainder of the matches, and then all
overlap scores are added to calculate the frequency for the
query set e1e3e4e5. This overall score denotes the frequency of
occurrence of this particular isoform in the data set. Roughly
speaking, if the overlap score of isoform X is twice the
overlap score of isoform Y, then X is twice as likely to occur
than Y.
skips to be considered, and specify the threshold value for the
minimum overlap to be considered significant. The tool is
automated in that, for any gene, one simply specifies the exon
file, the number of contiguous skips to be considered, and the
desired threshold value. SPLIT will then output the
frequencies of all the isoforms for that gene.





Figure 2. Overlap for each of three matches (= possible isoforms) resulting
from BLAST query eje3e4e5 (with exon 2 skipped). Numbers indicate the
fraction of nucleotides locally aligned between the BLAST result and the
given exon (e.g., Match 1 is a 0.2 match to exon 1 and 0.8 match to exon 3).
At this initial stage of our work we have considered all
possible contiguous skipping in an exon, such that the first
and the last exons are not skipped. This condition is required
for our frequency computation. For example, suppose we
have 10 exons in a gene sequence G abbreviated as e1e2....elo.
The number of possible contiguous queries that can be
generated for n exons is ((n-2) (n-1)) / 2. Thus, for a gene
with 10 exons, the number of queries generated (considering
all possible contiguous skipping) will be 8*9/2 = 36.




















C. SPLIT. The Alternative Splicing Toolkit
To compute the overlap score we developed a tool
(SPLIT) that uses the following Perl scripts: (1) Strip strips
the exon file of blank spaces before querying BLAST; (2)
FormQueries generates queries for all possible contiguous
skipping for a given set of exons; (3) RunBlast queries
BLAST for all the queries formed and outputs the result given
by BLAST for each query; and (4) Extract extracts the
pertinent information and calculates the frequency.
As an example, suppose we want to calculate the
frequency of a gene G that has 10 exons. We first provide a
file that contains all exons in the gene sequence, and specify
the number of contiguous skips to be considered. For
instance, the total number of possible contiguous skipping for
gene G is 36, and a maximum of 36 contiguous skipping
queries can be generated. But suppose the we want to
consider only those queries with a maximum of four
contiguous skips. To do this we specify four as the number of
IV. PRELIMINARY RESULTS
To demonstrate the efficacy of our approach, we tested
SPLIT on several genes common to the human and mouse.
Since CCDS is not comprehensive, there are genes for which
the exon structure for only one of the two species is known.
We executed SPLIT on 11 genes for which CCDS lists the
exon structure for human and mouse. Tables II and III show
the number of isoforms found by SPLIT for each gene of the
human and the mouse, respectively. In both tables the first
column lists the name ofthe gene, the second column lists the
number of exons present in a particular gene, the third column
lists the number of maximum queries generated for that
particular gene, and the fourth column lists the number of
isoforms found for that particular gene. Some of the rows in
Table III do not have values because those genes are not
available for the mouse in CCDS.
























































In the graph of Fig. 3, the x-axis shows the genes
considered, and the y-axis shows the number of isoforms
found by SPLIT. We see that for gene RNH1 the number of
isoforms for both species ranges from 0 to 28 plausible
isoforms. This result leads us toward the possibility that
certain isoforms ofRNH1 are significant for these species.
For OSCAR, we see that the number of isoforms for the
human is two, while no alternatively spliced isoforms were
found for the mouse. Again, it should be noted that for some
genes (e.g., PDE9A), the number of isoforms is more for the
human version than for the mouse version, whereas for other
genes (e.g., NF2), there are more isoforms for the mouse than
human.
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TABLE III. RESULTS FOR 15 MOUSE GENES





OSCAR 5 6 0
DRD3 7 15 1
RNH1 9 28 0
MCP 11 45 2
BRE 13 66 5
RGS12 16 105 1
NF2 16 105 8
CDC25B 1 7 119 7
PDE9A 18 136 9
BRCA1 22 210 6
OPAI 28 351 1
version. Two isoforms (the one in which exons 12-15 are
skipped, and the one in which exons 12-16 are skipped) have
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Due to space constraints, herein we only show isoform
frequency distributions for three human (BRCA1, PDE9A,
and DRD3) and three (BRCAI, PDE9A, and DRD3) mouse
genes. Fig. 4 and 5 show isoform frequency distributions for
BRCA1, Fig. 6 and 7 show isoform frequency distribution for
PDE9A, and Fig. 8 and 9 show isoform frequency
distributions for DRD3. Again, the number of potential
isoforms for each gene is shown in Tables II and III for the
human and mouse, respectively. Note that Fig. 4-7 show
queries for which the calculated frequency is greater than 0.
In Fig. 8 and 9 all potential isoforms (queries) are shown.
In Fig. 4 we show the frequency of occurrence of isoforms
for the human gene BRCA1. Out of the 78 potential isoforms
generated, only three are significant. From this figure we note
also that all of the isoforms (the one in which exon 12 is
skipped, the one in which exons 4-7 are skipped, and the one
in which exons 4-8 are skipped) have the same frequency (
2) of occurrence.
In Fig. 5 we show the frequency of occurrence of isoforms
for the mouse gene BRCA1 and compare it to that of the
human BRCA1 gene. Out of the 210 potential isoforms
generated, only six isoforms are significant. Note that the
mouse version of BRCA1 has more isoforms than the human
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Figure 6. Frequency of occurrence of isoform for human gene PDE9A.
In Fig. 6 we show the frequency of occurrence of isoforms
for the human gene PDE9A. Out of the 171 potential isoforms
generated, only 14 isoforms are significant. The isoform with
the highest frequency is the one in which exon 16 is skipped.
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Figure 7. Frequency of occurrence of isoform for mouse gene PDE9A.
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Figure 9. Frequency of occurrence of isoform for mouse gene DRD3.
In Fig. 7 we show the frequency of occurrence of isoforms
for the mouse gene PDE9A and compare it with the human
PDE9A gene. Out of the 136 potential isoforms generated,
only nine isoforms are significant. In this case, the human
version ofPDE9A has more isoforms than the mouse version.
The isoform with the highest frequency (approximately
13.47) is the one in which exon 2 is skipped.
In Fig. 8 we show the frequency of occurrence of isoforms
for the human gene DRD3. Out of the 10 potential isoforms
generated, only one isoform is significant. The isoform with
the highest frequency is the one in which exon 2 is skipped. It
has the highest frequency of occurrence (approximately 0.41)
in the data set.
In Fig. 9 we show the frequency of occurrence of isoforms
for the mouse gene DRD3, and compare it with human gene
DRD3. Out of the 15 potential isoforms generated, only one is
significant. The isoform with the highest frequency is the one
in which exon 2 is skipped. It has the highest frequency of
occurrence (approximately 0.48) in the data set. The results
for gene DRD3 are the same for both human and mouse; both
only show the isoform in which exon 2 is skipped with a
moderate amount of frequency of occurrence (0.41 for the
human, and 0.48 for the mouse).
V. FUTURE WORK
Although the preliminary results of our method are
promising, we plan to consider random skipping, which more
closely models biological reality. To improve the program's
exponential runtime, we will explore heuristics to reduce the
search space and improve the complexity of the algorithm.
VI. SIGNIFICANCE OF WORK
For many genes, isoforms have yet to be discovered.
Although alternative splicing can occur in all classes of genes,
it has been found to occur frequently in specific classes of
human genes e.g., those linked to the immune and nervous
systems. We believe that our approach could provide valuable
information for understanding isoform formation, and that, by
ranking isoforms by relevance to a disease, we may facilitate
focused experimentation on disease treatment and
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